• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺小叶原位癌和导管原位癌的管理

Management of lobular carcinoma in situ and ductal carcinoma in situ of the breast.

作者信息

Wood W C

机构信息

Emory University School of Medicine, Atlanta, Georgia, USA.

出版信息

Semin Oncol. 1996 Aug;23(4):446-52.

PMID:8757271
Abstract

Mammographic screening has resulted in an epidemic of diagnoses of ductal carcinoma in situ (DCIS). These are often small, impalpable lesions that do not reflect the natural history of older series of DCIS found by palpation at a larger size. The behavior of DCIS is related to the histological grade and size of the tumor. Therapy is primarily surgical excision. Irradiation has been shown to halve the rate of recurrence after local excision. Therapeutic decisions involving the extent of surgical excision and the addition of irradiation are based on considerations of tumor size and grade and the patient's age.

摘要

乳腺钼靶筛查导致了导管原位癌(DCIS)诊断的流行。这些通常是微小的、触诊不到的病变,与过去通过触诊发现的较大尺寸的DCIS系列病例的自然病程不同。DCIS的行为与肿瘤的组织学分级和大小有关。治疗主要是手术切除。放疗已被证明可使局部切除后的复发率减半。涉及手术切除范围和放疗添加的治疗决策基于肿瘤大小、分级以及患者年龄等因素的考虑。

相似文献

1
Management of lobular carcinoma in situ and ductal carcinoma in situ of the breast.乳腺小叶原位癌和导管原位癌的管理
Semin Oncol. 1996 Aug;23(4):446-52.
2
The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?小叶原位癌(LCIS)的管理。LCIS与导管原位癌(DCIS)相同吗?
Eur J Cancer. 2006 Sep;42(14):2205-11. doi: 10.1016/j.ejca.2006.03.019. Epub 2006 Jul 28.
3
[Carcinoma in situ. Prognostic factors].原位癌。预后因素
Arch Anat Cytol Pathol. 1994;42(5):234-50.
4
Lobular neoplasia: morphology and management.小叶瘤变:形态学与管理
Arch Pathol Lab Med. 2014 Oct;138(10):1344-9. doi: 10.5858/arpa.2014-0278-CC.
5
The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.导管原位癌(DCIS)的管理。乳腺癌护理与治疗临床实践指南指导委员会。加拿大放射肿瘤学家协会。
CMAJ. 1998 Feb 10;158 Suppl 3:S27-34.
6
Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.同时存在的增殖性高危病变对接受保乳治疗的导管原位癌患者同侧乳腺癌复发风险及对侧乳腺癌发生风险的影响。
Cancer. 2006 Jan 1;106(1):42-50. doi: 10.1002/cncr.21571.
7
Breast disease: a primer on diagnosis and management.乳腺疾病:诊断与管理入门
Int J Fertil Womens Med. 1997 Sep-Oct;42(5):278-87.
8
Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.导管原位癌治疗后局部复发的预测因素:一项荟萃分析。
Cancer. 1999 Feb 1;85(3):616-28.
9
8. The dilemma of in situ carcinoma of the breast.8. 乳腺原位癌的困境。
Int J Clin Pract. 2001 Dec;55(10):680-3.
10
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.应用USC/范纽斯预后指数的259例乳腺导管原位癌患者:长期随访的回顾性研究
Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9.